Carregant...
Telmisartan as tentative angiotensin receptor blocker therapeutic for COVID‐19
In late 2019, a new coronavirus emerged in Wuhan Province, China, causing lung complications similar to those produced by the SARS coronavirus in the 2002–2003 epidemic. This new disease was named COVID‐19 and the causative virus SARS‐CoV‐2. The SARS‐CoV‐2 virus enters the airway and binds, by means...
Guardat en:
| Publicat a: | Drug Dev Res |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley & Sons, Inc.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7267340/ https://ncbi.nlm.nih.gov/pubmed/32356926 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ddr.21679 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|